Brad Pick Highlights PPTA’s Insights on Plasma Therapies for Trauma, Surgery and Chronic Illnesses
Brad Pick, Senior Director Global External Communications at Grifols, shared a post by Plasma Protein Therapeutics Association (PPTA) on LinkedIn:
”What many don’t realize is that plasma therapeutics treat more than rare and chronic diseases. They have a vital role in treating everyday medical situations such as trauma and major surgery. That’s something all of us can relate to.”
Quoting Plasma Protein Therapeutics Association (PPTA)‘s post:
”Using specialized techniques, pooled plasma is separated and purified, and each protein undergoes advanced processes for therapeutic safety.
These manufacturing steps lead to plasma-derived medicines, such as albumin, immunoglobulins, coagulation factors, C1 esterase inhibitors, and Alpha-1 proteinase inhibitors.
These plasma-derived medicines are used to treat a range of conditions, from immunodeficiencies to blood clotting disorders, highlighting the critical role plasma proteins play in a variety of conditions – more of which are being discovered every day.
Learn more about the journey of plasma-derived medicines on our YouTube channel.”
See the Plasma Protein Therapeutics Association (PPTA) post here.
Stay updated with Hemostasis Today.
-
Nov 16, 2025, 19:46Ayodeji Olayanju: Academics Blood Matter Too!
-
Nov 16, 2025, 19:30Thomas Reiser Congratulates Saskia Middeldorp on Delivering the 2025 Sol Sherry Distinguished Lecture in Thrombosis
-
Nov 15, 2025, 15:47Shannon Farmer: Congratulations to Susan Goobie and Colleagues on Publication of Their Important Study
-
Nov 15, 2025, 15:46Fotios Barkas: Explore the Latest Articles From the Journal of Atherosclerosis Prevention and Treatment!
-
Nov 15, 2025, 15:45Ludovic Helfgott: Researchers Have Analysed Novo Nordisk Product Data in Obesity and Cardiovascular Disease
-
Nov 15, 2025, 15:42Haroun Gajraj Thanks Enric Roche for Demonstrating the Piston Effect
-
Nov 15, 2025, 15:41Thrombectomy Rates Rise 700% Nationwide
-
Nov 15, 2025, 15:41Emmanuel J. Favaloro: Transitioning Patients from DOACs to Heparin
-
Nov 15, 2025, 15:40Bruno Lima: I Owe a Lot of My Career to Dr. Brad Maron